J

Jeffrey S. Weber

NYU Langone Health

ORCID: 0000-0002-4962-2957

Publishes on Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Immunotherapy and Immune Responses. 1k papers and 95.5k citations.

PubIndex Score98Top 2%How it's scored

1kPublications

95.5kTotal Citations

First publication: 1987First senior author: 1974

Cancer Immunotherapy and Biomarkers CAR-T cell therapy research Immunotherapy and Immune Responses Melanoma and MAPK Pathways Cutaneous Melanoma Detection and Management

Top publicationsby citations

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

Julie R. Brahmer, John A. Thompson, Christina Lacchetti et al.|Journal of Clinical Oncology|2018

Cited by 3.7k

Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study

Jeffrey S. Weber, Tal Zaks, Matteo S. Carlino et al.|The Lancet|2024

Cited by 729

Imatinib for Melanomas Harboring Mutationally Activated or Amplified <i>KIT</i> Arising on Mucosal, Acral, and Chronically Sun-Damaged Skin

F. Stephen Hodi, David E. Fisher, Christopher L. Corless et al.|Journal of Clinical Oncology|2013

Cited by 594

Safety, Efficacy, and Biomarkers of Nivolumab With Vaccine in Ipilimumab-Refractory or -Naive Melanoma

Jeffrey S. Weber, Y. Ann Chen|Journal of Clinical Oncology|2013

Cited by 530

HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade

David Woods, Jeffrey S. Weber|Cancer Immunology Research|2015

Cited by 433